Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss.
D000328:Adult; D000368:Aged; D001299:Audiometry; D001309:Auditory Threshold; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D003639:Hearing Loss, Sudden / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage; D010952:Plasma Substitutes / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors; D014012:Tinnitus / Q000175:diagnosis* / Q000628:therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage
D003911:Dextrans; D005938:Glucocorticoids; D010952:Plasma Substitutes; D014665:Vasodilator Agents; D010208:Papaverine; D011241:Prednisone